MAPPING MELANOMA METASTASIS SUPPRESSOR GENE(S)

Project: Research project

Project Details

Description

DESCRIPTION: (Adapted from the investigator's abstract) As metastasis (i.e.,
tumor spread) is the most life-threatening complication of cancer.
Identification of genes that regulate the spread of cancer is of utmost
importance to reduce cancer deaths. Malignant melanoma serves as a good in vivo
model for study of the metastatic process. Understanding the genetic changes in
melanoma cells that are responsible for its metastatic phenotype is crucial for
improvements in melanoma treatment and survival, and may relate to other solid
tumor types as well. The long-term goal of this research is to identify the
gene on chromosome 6 (#6) that regulates metastatic potential in cutaneous
malignant melanoma.

Transfer of a normal copy of #6 into human melanoma cell lines that form tumors
and metastasizes in immunodeficient mice results in suppression of tumor spread
(i.e. metastasis) without reducing tumor formation. These data suggest that a
metastasis-suppressor gene (MSG) is located on #6. More recently, the location
of the MSG has been narrowed to 6q16.3-q23 ( about40Mb) by similar studies
using #6 fragment. Presently our laboratory has hybrid cells that contain a
transferred #6 deleted at 6q21 ( about4Mb), a region frequently lost in many
types of advanced cancers. These cells await evaluation in metastasis assays.

Thus, the first specific aim is to narrow the region on #6 that encodes the
metastasis-suppressor gene by evaluating hybrid melanoma cell lines with a
transferred #6 deleted at 6q21 in metastasis assays.

The second specific aim will be to further refine the location of the melanoma
suppressor gene by identifying BAC, PAC, and/or YAC clones that span the region
located at 6q16.3-q23.

Selecting overlapping PACs and BACs that cover the region implicated in
metastasis suppression will be introduced into the melanoma cell line.
Transfected clones will be monitored for suppression of metastasis in
immunodeficient mice,

These studies will narrow the region of the MSG to
StatusFinished
Effective start/end date4/1/013/31/04

Funding

  • National Cancer Institute: $150,000.00

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.